Asthma trials in Poland

In Poland 26 Also abroad 500

26 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma
Where
Lodz, Tarnów
Age
6 years to 11 years
People
42 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05222529 · EU 2024-511382-11-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
Where
Bialystok, Krakow, Lublin, Piaseczno, Tarnów, Torun
Age
12 years to 17 years
People
188 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05776927
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Where
Lodz, Tarnów
Age
5 years to 11 years
People
231 worldwide
Run by
AstraZeneca
See details and how to joinNCT06023589
Phase 3Taking people
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
Where
Chęciny, Gdansk, Lodz
Age
6 years and over
People
230 worldwide
Run by
AstraZeneca
See details and how to joinNCT07444567
Phase 3Not yet taking people in Poland
Clinical trial to assess the efficacy and safety of a vaccine for grass pollen allergy.
Where
Bialystok, Cracow, Łódź, Poznan, Suwalki, Wolomin, Wrocław
Age
Up to 64 years
People
171 worldwide
Run by
Inmunotek S.L.
See details and how to join2026-526100-73-00 · EU 2026-526100-73-00
Phase 1Taking people
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
Where
Jozefow
Age
18 years to 65 years
People
84 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06433921 · EU 2024-511220-14-00
Phase 2Taking people
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Where
Bychawa, Cracow, Poznan, Sosnowiec, Tarnów, Wroc?aw
Age
18 years to 75 years
People
252 worldwide
Run by
Pfizer
See details and how to joinNCT06977581 · EU 2024-517866-40-00
Phase 2Taking people
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Where
Krakow, Poznan
Age
18 years to 75 years
People
531 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07219173
Phase 2Taking people
A Prospective, Randomized, Open-label, Multicentre Study to Compare the Safety of PURETHAL Mites Mixture 50,000 AUeq/mL Rush Up-Dosing Regimen with the Conventional Up-Dosing Regimen in Adult Participants with Allergic House Dust Mite Rhinitis/Rhinoconjunctivitis with or without Asthma.
Where
Bialystok, Białystok, Cracow, Gryfice, Katowice, Kielce, Lodz, Lublin, Poznan, Skarzysko-Kamienna, Warsaw
Age
18 years to 64 years
People
120 worldwide
Run by
HAL Allergy B.V.
See details and how to join2026-526908-72-00 · EU 2026-526908-72-00
Phase 2Taking people
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
Where
Lodz, Tarnów
Age
4 years to 11 years
People
69 worldwide
Run by
AstraZeneca
See details and how to joinNCT07525375 · EU 2025-524914-26-00
Phase 2Taking people
A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study
Where
Poznan
Age
18 years and over
People
264 worldwide
Run by
Kymera Therapeutics, Inc.
See details and how to joinNCT07677059
Phase 2Taking people
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Where
Bialystok, Gdansk, Lodz, Poznan, Sosnowiec, Tarnów, Trzebnica, Wroclaw, Zawadzkie
Age
18 years to 75 years
People
264 worldwide
Run by
Kymera Therapeutics, Inc.
See details and how to joinNCT07323654
Phase 2Not yet taking people in Poland
A Long-term Study of KT-621 Administered Orally to Participants with Asthma Previously Enrolled in a KT-621 Asthma Study
Where
Bialystok, Gdansk, Lodz, Łódź, Poznan, Sosnowiec, Tarnów, Trzebnica, Wroclaw, Zawadzkie
Age
18 years and over
People
77 worldwide
Run by
Kymera Therapeutics Inc.
See details and how to join2026-526241-98-00 · EU 2026-526241-98-00
Phase 2Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Where
Checiny, Katowice, Lodz, Ostrowiec Świętokrzyski, Poznan
Age
18 years and over
People
900 worldwide
Run by
Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00
Phase 2Taking people
A Study of KT-621 Administered Orally to Adult Participants with Moderate to Severe Eosinophilic Asthma
Where
Bialystok, Gdansk, Lodz, Łódź, Poznan, Sosnowiec, Tarnów, Trzebnica, Wroclaw, Zawadzkie
Age
18 years and over
People
121 worldwide
Run by
Kymera Therapeutics Inc.
See details and how to join2025-523180-38-00 · EU 2025-523180-38-00
Phase 3Taking people
ROSY-F: Roll-over Study for Participants Who Have Completed a Previous Clinical Study with Benralizumab (Fasenra) and Benefit from Continued Treatment
Where
Checiny, Gdansk, Lodz
People
94 worldwide
Run by
AstraZeneca AB
See details and how to join2025-523307-29-00 · EU 2025-523307-29-00
Phase 2Taking people
A Study to Evaluate Brenipatide Compared with Placebo in Adult Participants with Uncontrolled Moderate to Severe Asthma
Where
Cracow, Poznan
Age
18 years to 64 years
People
137 worldwide
Run by
Eli Lilly & Co.
See details and how to join2025-522640-41-00 · EU 2025-522640-41-00
No phaseTaking people
Expression of TSLP Isoforms in Asthma
Where
Warsaw
Age
18 years and over
People
70
Run by
Medical University of Warsaw
See details and how to joinNCT07786870
Phase 3Enrolling by invitation
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
Where
Lodz, Tarnów, Warsaw
Age
2 years to 5 years
People
90 worldwide
Run by
Sanofi
See details and how to joinNCT06191315 · EU 2023-504331-41-00
Phase 3Taking people
A double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluate the efficacy and safety of QVM149 (indacaterol acetate / glycopyrronium bromide / mometasone furoate) compared to salmeterol xinafoate/fluticasone propionate in children from 12 years to less than 18 years of age with asthma.
Where
Bialystok, Cracow, Lodz, Lublin, Piaseczno, Rzeszów, Tarnów, Torun
Age
Up to 17 years
People
68 worldwide
Run by
Novartis Pharma AG
See details and how to join2022-502365-26-00 · EU 2022-502365-26-00
Phase 4Taking people
BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
Where
Bialystok, Białystok, Chorzow, Cracow, Kielce, Lodz, Lublin, Makow Podhalanski, Ostrowiec Świętokrzyski, Sosnowiec, Strzelce Opolskie, Tarnów, Warsaw, Wroclaw
Age
18 years and over
People
644 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07666490 · EU 2025-524289-56-00
No phaseTaking people
Biomarkers and Respiratory Omics as New CHildren Opportunities - Study of Clinical Outcomes and Predictivity Evaluation
Where
Warsaw
Age
Up to 17 years
People
160
Run by
Medical University of Warsaw
See details and how to joinNCT07232550
Phase 2Taking people
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Where
Makow Podhalanski, Nowa Sol, Piaseczno, Radom, Sosnowiec, Wroc?aw, Wrocław
Age
18 years to 75 years
People
512 worldwide
Run by
Kinaset Therapeutics Inc
See details and how to joinNCT07532265 · EU 2023-509125-41-00
Phase 1Taking people
A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
Where
Bydgoszcz, Cracow, Gdansk, Nadarzyn, Szczecin
Age
18 years to 80 years
People
286 worldwide
Run by
Bambusa Therapeutics
See details and how to joinNCT06944925 · EU 2025-523142-28-00
Phase 2Taking people
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
Where
Bialystok, Cracow, Elblag, Lodz, Lublin, Ostróda, Ostrowiec Świętokrzyski, Piaseczno, Poznan, Rzeszów, Skierniewice, Sopot, Sosnowiec, Strzelce Opolskie, Tarnów, Warsaw, Wroclaw, Wrocław
Age
18 years to 75 years
People
780 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07301736 · EU 2025-521456-35-00